Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DaVita Inc DVA

Healthcare
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers... see more

Recent & Breaking News (NYSE:DVA)

DaVita expands paid leave to support teammates choosing to be living organ donors

PR Newswire February 14, 2022

DaVita Inc. 4th Quarter 2021 Results

PR Newswire February 10, 2022

Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022

GlobeNewswire February 10, 2022

DaVita Inc. Schedules 4th Quarter 2021 Investor Conference Call

PR Newswire January 27, 2022

Kidney Doctors, Transplant Providers Work with DaVita in New Government Program to Help Improve the Lives of Medicare Patients with Kidney Disease

PR Newswire January 19, 2022

DaVita Acquires MedSleuth, Deepens Efforts to Improve Transplant Experience

PR Newswire January 18, 2022

DaVita Teammates Transformed Care for Thousands of Patients in 2021

PR Newswire January 12, 2022

DaVita Celebrates 10 Years of Kidney Smart® Educational Programming

PR Newswire January 6, 2022

DaVita Integrated Kidney Care Expands Clinical Leadership Team

PR Newswire December 16, 2021

DaVita's North American Operations Now Powered by 100% Renewable Energy

PR Newswire December 9, 2021

15th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life

PR Newswire November 30, 2021

DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 Vaccines in Dialysis Patients

PR Newswire November 29, 2021

WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP: VILLAGEHEALTH AND DA VITA, INC. DATA BREACH INVESTIGATION ALERT

PR Newswire November 11, 2021

DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2021

PR Newswire November 4, 2021

The American Diabetes Association® and DaVita Raise Awareness about the Link between Diabetes and Kidney Disease during American Diabetes Month®

PR Newswire November 1, 2021

DaVita Inc. 3rd Quarter 2021 Results

PR Newswire October 28, 2021

Renalytix Reports Full Year Fiscal 2021 Results

GlobeNewswire October 21, 2021

DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021

PR Newswire October 19, 2021

DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call

PR Newswire October 19, 2021

DaVita Climate Action Goals Approved by the Science Based Target Initiative

PR Newswire October 11, 2021